Expert Testimony

DFCR Updates

Doctors for Cannabis Regulation (DFCR) Urges the United States Federal Government to Prioritize the Immediate Release of Brittney Griner from Detention in Russia

Expert Testimony

Kansas Senate Bill SB 560

6/29/22

Expert Testimony

DFCR Calls for Delaware Veto Override of HB 371 - Cannabis Legalization

6/2/22

Expert Testimony

DFCR Letter to the House in Strong Support of the MORE Act

2/24/22

Expert Testimony

Delaware House Health and Human Development Committee HB 305

1/26/22

Expert Testimony

New Jersey Senate Judiciary SB2703

11/1/18

Expert Testimony

US Senate Cannabis Administration and Opportunity Act

1/1/21

Expert Testimony

New York General Assembly

12/1/18

Expert Testimony

South Carolina Medical Affairs S.366

4/1/19

4/26/21

1/1/20

1/1/20

1/1/20

Colorado House Public & Behavioral Health & Human Services HB21-1317

5/18/21

Expert Testimony

Colorado Senate Medical Marijuana Code SB218

5/10/19

Expert Testimony

Comments in Response to the Cannabis Administration and Opportunity Act (CAOA)

1/1/21

Expert Testimony

Testimony before the Illinois Senate on Marijuana Legalization

1/22/18

Expert Testimony

DFCR Letter to the House in Support of the MORE Act

10/1/21

Expert Testimony

New Jersey Cannabis Regulatory Commission: High potency THC, Edibles

6/2/21

Expert Testimony

Texas House Criminal Jurisprudence Committee HB3772

Bryon Adinoff, MD

4/20/21

Expert Testimony

Delaware House Human Health Committee HB150

Bryon Adinoff, MD

3/24/21

Expert Testimony

Delaware House Human Health Committee HB150

David L. Nathan, MD, DFAPA

3/24/21

Expert Testimony

New Jersey Assembly Oversight, Reform and Federal Relations

David L. Nathan, MD, DFAPA

11/10/20

Expert Testimony

New Jersey Assembly Appropriations: Regulations

David L. Nathan, MD, DFAPA

11/20/20

Expert Testimony

Connecticut General Assembly Judiciary SB888

Bryon Adinoff, MD

2/25/21

Expert Testimony

New York Legislature CRTA

Tanya Adams, DO

2/23/21

Expert Testimony

Connecticut General Assembly Judiciary SB888

Hugh Blumenfeld, MD, PhD

3/1/21

Expert Testimony

New Jersey Senate Judiciary AB1898

David L. Nathan, MD, DFAPA

2/22/21

Expert Testimony

Virginia Senate: Adult Use Cannabis

Bryon Adinoff, MD

1/31/21

Expert Testimony

New Jersey Senate Judiciary Cannabis Adult Use

David L. Nathan, MD, DFAPA

6/19/17

Expert Testimony

New Jersey General Assembly CR840

Monica Taing, PharmD

12/12/19

Expert Testimony

California State Assembly AB1606

DFCR

4/14/17

Expert Testimony

Vermont House Government Operations SB54

David L. Nathan, MD, DFAPA

4/30/19

Expert Testimony

Connecticut Senate Judiciary SB16

David L. Nathan, MD, DFAPA

3/3/20

Expert Testimony

Kansas Senate Federal and State Affairs SB366

Wendy Askew, MD

10/23/19

Expert Testimony

Kansas Senate Federal and State Affairs SB366

Rachel Knox, MD

10/23/19

Expert Testimony

Kansas Senate Federal and State Affairs SB366

Donald O. Lyman, MD, DTPH

10/23/19

Expert Testimony

Kansas Senate Federal and State Affairs SB366

Genester Wilson-King, MD, FACOG

10/23/19

Expert Testimony

Kansas Senate Federal and State Affairs SB366

Bryon Adinoff, MD

10/23/19

Expert Testimony

Connecticut Senate Judiciary SB16

Bryon Adinoff, MD

3/3/20

Expert Testimony

US House Subcommittee Cannabis Policies for the New Decade

David L. Nathan, MD, DFAPA

1/18/20

Expert Testimony

Texas House Criminal Jurisprudence HB63

Bryon Adinoff, MD

3/4/19

Expert Testimony

Vermont Senate Judiciary SB54

David L. Nathan, MD, DFAPA

2/1/19

Expert Testimony

Rhode Island House Judiciary HB5555

David L. Nathan, MD, DFAPA

4/12/17

Expert Testimony

New York Assembly Codes, Health, Governmental Operations, Alcoholism and Drug Abuse

David L. Nathan, MD, DFAPA

10/17/18

Expert Testimony

New Jersey Senate Judiciary SB2703

David L. Nathan, MD, DFAPA

3/19/19

Expert Testimony

New Jersey Assembly Oversight, Reform and Federal Relations Committee on Cannabis Legalization

David L. Nathan, MD, DFAPA

3/6/18

Expert Testimony

New Jersey Division of Consumer Affairs Marijuana Reclassification

David L. Nathan, MD, DFAPA

4/25/18

Expert Testimony

New Jersey Senate Judiciary

David L. Nathan, MD, DFAPA

11/17/15

Expert Testimony

Illinois General Assembly SB316

David L. Nathan, MD, DFAPA

1/23/18

Expert Testimony

Delaware House Revenue & Finance HB110

David L. Nathan, MD, DFAPA

5/11/17

Expert Testimony

Vermont House Human Services H.170

Bryon Adinoff, MD

4/12/17

Expert Testimony

Texas House Criminal Jurisprudence HB2107

Bryon Adinoff, MD

5/3/17

Expert Testimony

Texas House Criminal Jurisprudence HB81

Bryon Adinoff, MD

3/14/17

Expert Testimony

Delaware House Revenue & Finance HB110

Bryon Adinoff, MD

6/5/19

Expert Testimony

South Carolina Medical Affairs S.366

Bryon Adinoff, MD

4/6/19

Expert Testimony

Texas House Public Health HB1365

Bryon Adinoff, MD

3/16/19

Expert Testimony

U.S. FDA Cannabis Scheduling

David L. Nathan, MD, DFAPA

4/23/18

Expert Testimony

Connecticut Commission on Women, Children and Seniors Cannabis Forum (Video)

David L. Nathan, MD, DFAPA

4/30/18

Expert Testimony

U.S. House: Congressional Committee Hearing on Cannabis Legalization

David L. Nathan, MD, DFAPA

7/10/19

Expert Testimony

Categories

Browse by Location

Follow

Contact Us

DFCR News & Events